Zobrazeno 1 - 10
of 19
pro vyhledávání: '"L. Brian Cross"'
Autor:
Joel C. Marrs, Jeffrey O. Ekoma, Lucas G. Hill, L. Brian Cross, William G. Lang, Jeffrey Bratberg, Heather Brennan Congdon, Sarah McBane, Ronald P. Jordan
Based on the growing importance of community engagement and the recognition of its importance by the American Association of Colleges of Pharmacy (AACP), the committee offers several examples of community engagement activities for consideration and r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0ce15ac866ce86eb4289a8f2bd84c9
https://europepmc.org/articles/PMC5701333/
https://europepmc.org/articles/PMC5701333/
Publikováno v:
American Journal of Health-System Pharmacy. 72:1086-1088
The recent availability of nonprescription intranasal corticosteroids presents a risk to patients receiving protease inhibitors and other regimens containing pharmacokinetic enhancers.[1][1] However, the significance of this risk may not be fully app
Autor:
Rick Hess, L. Brian Cross
Publikováno v:
Postgraduate Medicine. 125:62-72
Lorcaserin represents a new serotonergic medication used as an adjunct to a reduced-calorie diet and increased physical activity treatment plan for chronic weight management in adult patients with an initial body mass index ≥ 30 kg/m 2 or in adult
Publikováno v:
Home Health Care Management & Practice. 26:39-44
Heart failure (HF) affects 6 million Americans, has an expected increasing prevalence in the next 20 years, and has a 5-year mortality rate of 50%. It represents the number one reason for hospitalization in patients older than 65 years. Recent legisl
Autor:
Michael P. Kane, Krystal L. Edwards, L. Brian Cross, Daniel M. Riche, Rosalyn S. Padiyara, Jeffrey S. Stroup, Jennifer D. Goldman-Levine
Publikováno v:
Pharmacotherapy. 30:955-965
Diabetes mellitus has reached epidemic proportions worldwide, eliciting extensive research on both the disease process and its treatment. Regardless of diabetes type, the progressive nature of the disease makes insulin the long-term mainstay of diabe
Autor:
Andrea S. Franks, L Brian Cross
Publikováno v:
Disease Management & Health Outcomes. 13:31-42
The burden of cardiovascular disease in America continues to be the leading cause of death and costs significantly more to treat ($US298.2 billion in 2002) than any other disease in the US healthcare system. Incontrovertible evidence links elevated l
Publikováno v:
Expert Review of Cardiovascular Therapy. 11:289-291
The number of myocardial infarctions (MIs) in population remains high and this event is a significant predictor of mortality. Information in the literature points to a reduction in mortality, reinfarction and sudden death in first year, especially in
Publikováno v:
Annals of Pharmacotherapy. 38:1726-1730
OBJECTIVE To review the literature for treatment of migraine headaches with sumatriptan during pregnancy. DATA SOURCES Studies and reports were located in International Pharmaceutical Abstracts (1970-September 2003) and MEDLINE (1966-week 3 September
Autor:
L. Brian Cross, Douglas Meyer, Scott D. Hanes, Tara Jenkins, Amy L. Pittenger, Stefanie P. Ferreri
Publikováno v:
American Journal of Pharmaceutical Education. 81:63
Objective. To evaluate the talents of fellows from cohorts 1-10 of the Academic Leadership Fellows Program (ALFP). Methods. This was a descriptive analysis of previously collected ALFP cohort data reflecting the talents using the Clifton StrengthsFin
Publikováno v:
Pharmacotherapy. 29:121-123
The effect of treatment for hepatitis C viral infection on hemoglobin A(1c) (A1C) levels is not well described in the literature. We describe a 59-year-old man with type 2 diabetes mellitus whose A1C level became falsely low when ribavirin and pegint